IBRX
ImmunityBio Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website immunitybio.com
- Employees(FY) 670
- ISIN US45256X1037
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: IBRX
Overview
In this investment analysis report, we will delve into the financial statements of IBRX, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of IBRX 2024-04-26
Overview:
In the last 5 trading days, IBRX stock has shown significant price fluctuations, with the closing price ranging from 4.82 to 7.35. Various technical indicators have been analyzed to provide insights into the potential future price movement of IBRX stock. The analysis covers trend indicators, momentum indicators, volatility indicators, ...
Recent News & Updates
- 2024-05-02 16:04
- 2024-05-02 04:04
- 2024-04-30 22:05
- 2024-04-30 08:00
- 2024-04-29 20:00
- 2024-04-25 00:03
- 2024-04-25 00:03
- 2024-04-23 16:55
ImmunityBio's bladder cancer therapy wins FDA approval(Yahoo Finance Video)
- 2024-04-22 21:56
- 2024-04-22 09:56
- 2024-04-18 23:02
12 Most Shorted Stocks in 2024(Insidermonkey)
- 2024-03-19 09:53
- 2024-03-13 20:45
- 2024-03-06 09:00
- 2024-03-05 20:00
- 2024-03-05 09:00
- 2024-03-04 20:00
- 2024-02-21 09:00
- 2024-02-20 20:00
- 2024-02-13 05:17
ImmunityBio, Inc. (NASDAQ:IBRX): When Will It Breakeven?(Simply Wall St.)
- 2024-02-05 09:00
- 2024-02-04 20:00
- 2024-01-02 18:10
- 2024-01-02 06:00
- 2023-11-16 09:00
- 2023-11-15 20:00
- 2023-11-07 09:00
- 2023-11-06 20:00
- 2023-10-26 09:00
- 2023-10-25 21:00